Jun 30, 2026

Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics:

• Introduction (0:00)
• Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)
• Therapeutic Approaches Targeting ALK and ROS1 — Dr Langer (31:56)

CME information and select...

Jun 29, 2026

Featuring perspectives from Dr Erika Hamilton, Dr Jane Lowe Meisel, Dr Joyce O’Shaughnessy and Dr Seth Wander, including the following topics:

• Introduction (0:00)
• Current and Future Management of HR-Positive, HER2-Negative Localized Breast Cancer — Dr Meisel(2:40)
• Optimizing First-Line Therapy for Patients with...

Jun 28, 2026

Featuring perspectives from Dr Courtney D DiNardo and Dr Harry Paul Erba, including the following topics:

• Introduction (0:00)
• Current Management Approaches for FLT3- and IDH-Mutated Acute Myeloid Leukemia (AML) — Dr DiNardo (9:44)
• Current and Future Role of Menin Inhibitors for Patients with AML — Dr Erba (32:07)

Jun 27, 2026

Featuring perspectives from Dr Mrinal Gounder and Dr Richard F Riedel, including the following topics:

• Introduction (0:00)
• Desmoid Tumors — Dr Gounder (2:58)
• Soft Tissue Sarcoma — Dr Riedel (28:29)

CME information and select publications

Jun 27, 2026

Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:

• Introduction (0:00)
• Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:38)
• Nonmetastatic EGFR-Mutated NSCLC, Exon 20 Insertion Mutations and Novel Agents — Dr...